AETHLON MEDICAL INC (AEMD) › Total AssetsAETHLON MEDICAL INC (AEMD) — Total AssetsAnnual figures by period end, from SEC filings.2011-03-31: $567.2K2012-03-31: $838.7K2013-03-31: $496.7K2014-03-31: $1.70M2015-03-31: $1.38M2016-03-31: $2.53M2017-03-31: $1.73M2018-03-31: $7.35M2019-03-31: $4.12M2020-03-31: $10.39M2021-03-31: $10.67M2022-03-31: $19.42M2023-03-31: $17.51M2024-03-31: $8.25M2025-03-31: $7.36M2026-03-31: $6.33M$6.33M2011-03-31Total Assets (USD)2026-03-31Period endedTotal AssetsChange YoYSource filing2026-03-31$6.33M-13.9%2026-06-10Balance as of period end2025-03-31$7.36M-10.8%2026-06-10Balance as of period end2024-03-31$8.25M-52.9%2025-06-26Balance as of period end2023-03-31$17.51M-9.8%2024-06-27Balance as of period end2022-03-31$19.42M+82.0%2023-06-28Balance as of period end2021-03-31$10.67M+2.7%2022-06-28Balance as of period end2020-03-31$10.39M+151.9%2021-06-24Balance as of period end2019-03-31$4.12M-43.9%2020-06-25Balance as of period end2018-03-31$7.35M+325.9%2019-07-01Balance as of period end2017-03-31$1.73M-31.7%2018-06-08Balance as of period end2016-03-31$2.53M+83.2%2017-06-28Balance as of period end2015-03-31$1.38M-18.6%2016-06-29Balance as of period end2014-03-31$1.70M+241.3%2015-07-13Balance as of period end2013-03-31$496.7K-40.8%2014-07-15Balance as of period end2012-03-31$838.7K+47.9%2013-07-15Balance as of period end2011-03-31$567.2K—2012-06-29Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)